Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-label, Single Arm, Roll-over Study to Provide Continued Treatment With Darolutamide in Participants Who Were Enrolled in Previous Bayer Sponsored Studies

NCT04464226 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT04464226
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04464226 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-label, Single Arm, Roll-over Study to Provide Continued Treatment With Darolutamide in Participants Who Were Enrolled in Previous Bayer Sponsored Studies
Lead sponsor
Bayer
Phase
Phase 3
Overall status
Active, not recruiting
Start date
October 20, 2020
Completion date
June 26, 2028
Enrollment
402 (estimated)
Sites
335

Conditions

As the registry lists them; a condition with its own page is linked.

cancer